Results 101 to 110 of about 1,731 (192)

Biomimetic nanoplatform with multienzyme cascade activity boosting ROS generation and immune activation feedback for tumor therapy. [PDF]

Mater Today Bio
Bai C, Hu P, Ni Z, Xie J, Cai F, Wang J, Wang X, Guo D.   +7 more
europepmc   +1 more source

The autophagy switch: A critical determinant of arsenic-induced carcinogenesis and cancer therapy. [PDF]

Toxicol Rep
Zeinvand-Lorestani M, Rahim F, Zeinvand-Lorestani H.   +2 more
europepmc   +1 more source

Multisystem toxicity and non-cirrhotic portal hypertension linked to arsenic exposure from a traditional herbal preparation. [PDF]

Gastroenterol Rep (Oxf)
Deng Y, Zhang G, Duan W, Zhao X.
europepmc   +1 more source

Nuclear Magnetic Resonance Based Metabolomics-A Rising Star in Traditional Chinese Medicine Research. [PDF]

Pharmaceuticals (Basel)
Hu Y, Liu L, Yan G, Bai L, Yang L, Kong L, Sun H, Liu C, Sun Y, Han Y, Wang X.   +10 more
europepmc   +1 more source

Chronic arsenic poisoning. [PDF]

QJM
Dong R, Jiao Y.
europepmc   +1 more source

Realgar-Indigo naturalis Formulation [PDF]

, 2020
openaire   +1 more source

Effects of realgar-indigo naturalis formula on a zebrafish tumor xenograft model induced by human acute promyelocytic leukemia cells: antitumor activity, hepatotoxicity, and transcriptomic analysis. [PDF]

Front Pharmacol
Bai D, Zhang Z, Gao J, Wang Q, Macdonald R, Xu Z, Chen S, Huang N, Luo L.   +8 more
europepmc   +1 more source

Efficacy and safety of the commercial Chinese polyherbal preparation <i>Liu Shen Wan</i> as an adjunctive treatment for herpes zoster and postherpetic neuralgia: a systematic review and meta-analysis. [PDF]

Front Pharmacol
Li Y, Zhang L, Wang W, Zhao H, Liao X.
europepmc   +1 more source

Dual inhibition of FAS and HAS2/3 by 4-MU in Realgar-Coptis chinensis unveils a metabolic checkpoint for liver cancer therapy. [PDF]

Nat Prod Bioprospect
Wu S, Wang Y, Deng D, Zheng G, Mei H, Wang C, Zheng X, Gui C, Liao F, Xiang M.   +9 more
europepmc   +1 more source

Acid ground nano-realgar processed product inhibits breast cancer by inducing mitophagy via the p53/BNIP3/NIX pathway. [PDF]

J Cell Mol Med, 2023
Fang J, Zou X, Gong L, Xi J, Liu Y, Yang X, Zhang X, Gui C.   +7 more
europepmc   +1 more source